[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Omicron BA. 2 will displace BA. 1", "description": "Omicron is out competing omicron\n\nCurrent symptoms\n\nRunny nose, 73%\n\nHeadache, 68%\n\nFatigue, 64%\n\nSneezing, 60%\n\nSore throat, 60%\n\nPersistent cough, 44%\n\nHoarse voice, 36%\n\nChills or shivers, 30%\n\nFever, 29%\n\nDizzy, 28%\n\nBrain fog, 24%\n\nAltered smell, 23%\n\nSore eyes, 23%\n\nUnusual muscle pains, 23%\n\nSkipped meals, 21%\n\nLoss of smell, 19%\n\nChest pain, 19%\n\nSwollen glands, 19%\n\nFeeling down, 16%\nONS\n\nhttps://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights\n\nhttps://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19latestinsights/deaths#pre-existing-health-conditions\n\nPrevalence, week ending 22 January 2022\n\nEngland, 2,629,400 people, 1 in 20\n\nWales, 99,500 people, 1 in 30\n\nScotland, 163,600 people, 1 in 30\n\nNorthern Ireland, 96,500 people, 1 in 20\n\nDouble vaccinated less likely to report long COVID\n\nCompared to unvaccinated when infected\n\n41.1% decrease in the likelihood of self-reported long COVID at least 12 weeks later \n\nRisk of COVID-19 death higher for most ethnic minority groups\n\nRisk of death involving COVID-19 was higher for people from all ethnic minority groups,\n\nexcept for Chinese men and women\n\nBangladeshi group\n\nWomen, 5.2 times higher than White British group\n\nMen, 4.4 times higher than White British group\n\nZoe, Omicron bounces back\n\nhttps://covid.joinzoe.com/post/omicron-bounces-back\n\n159,486 new daily symptomatic cases of COVID in the UK\n\nAn increase of 10% from 144,527 reported last week\n\nUK R value, around 1.0 \n\nPrevalence\n\nOne in 30 people in the UK currently have symptomatic COVID\n\nProfessor Tim Spector\n\nEnd of school holidays repeatedly usher in a rapid rise in cases among children\n\nA new subtype of Omicron is taking over called BA.2\n\nOne in 20 new cases had this variant last week, and as it's doubling every few days,\n\nthis should predominate within a month. \n\nNatural infection with Delta may not offer much protection. \n\nI expect that cases will continue to stay high until spring. \n\nMost vaccinated infections are mild, \n\nwith symptoms lasting on average for a shorter time than Delta\n\nwith less severe cases. \n\nVulnerable groups\n\nUK data\n\nhttps://coronavirus.data.gov.uk\n\nUS cases and deaths data\n\nhttps://covid.cdc.gov/covid-data-tracker/#trends_dailycases\n\nSouth Africa references\n\nhttps://twitter.com/rid1tweets\n\nhttps://www.nicd.ac.za/diseases-a-z-index/disease-index-covid-19/surveillance-reports/daily-hospital-surveillance-datcov-report/", "link": "https://www.youtube.com/watch?v=xMLZepCMFQo", "date_published": "2022-01-27 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Daughter of omicron", "description": "Thanks to Kev, I have uploaded a version of this without the hiss\n\nOmicron BA.2 Variant, is this going to be another wave?\n\nIf you would like John\u2019s text books, (it is free to download the PDFs)\n\nLink to free download of my 2 textbooks\n\nhttp://159.69.48.3/\n\nPhysiology book in hard copy\nhttps://www.ebay.co.uk/itm/154770452796?mkevt=1&mkcid=16&mkrid=710-127635-2958-0\n\nPathophysiology book in hard copy\nhttps://www.ebay.co.uk/itm/154770451780?mkevt=1&mkcid=16&mkrid=710-127635-2958-0\n\n\nOriginal omicron, B.1.1.529\n\nhttps://www.who.int/en/activities/tracking-SARS-CoV-2-variants/\n\nPANGO Lineage is described as a cluster of sequences that are associated with an epidemiological event,\n\nPhylogenetic Assignment of Named Global Outbreak Lineages (PANGOLIN) \n\nOmicron includes Pango lineage B.1.1.529 and descendent Pango lineages BA.1, BA.1.1, BA.2 and BA.3. \n\nBA.2 is a descendent lineage\n\n\u2018Omicron plus\u2019\n\nIdentified, Philippines, then to India\n\nhttps://www.medpagetoday.com/special-reports/exclusives/96833\n\nhttps://www.independent.co.uk/news/science/covid-omicron-variant-ba2-latest-b2000044.html\n\nOmicron sublineage BA.2\n\n10,000 cases of BA.2, 40 countries\n\nPotentially increased transmissibility over omicron clade BA.1\n\nU.K. Health Security Agency, VUI\n\nCases doubling every 4 days\n\n120% growth advantage over original Omicron clade\n\n(Delta to Omicron, 500% growth advantage)\n\nSimilar growth, Denmark, Norway, Sweden, India\n\nDoes not have the same s-gene target failure on PCR as omicron BA.1\n\nBA.2 is S gene positive\n\nBA.1, 60 mutations\n\nBA.2, 80 mutations\nhttps://www.telegraph.co.uk/global-health/science-and-disease/ba2-new-omicron-sub-variant-could-prolong-uk-epidemic-warn-experts/\n\nMeaghan Kall, UKHSA\n\nhttps://twitter.com/kallmemeg/status/1485198018953555969\n\nno evidence at all yet that it can evade Omicron (BA.1) immunity or be different to Omicron in any meaningful way\n\nVariants will continue to emerge, but not all variants will be a problem\n\nOnly having a transmissibility advantage at this stage of the game (with population immunity so high) isn't a total showstopper\n\nLittle difference in vaccine effectiveness between BA.1 and BA.2\n\nDisease severity, comparable to BA.1\n\nUnlikely to be another BA.2 omicron wave\n\nDenmark\n\nBA.2 now accounts for 65% of new cases\n\nEarly data, not been associated with an increase in hospitalisations\n\nNorway\n\nIncrease in BA.2 in Oslo\nConcurred that BA.2 is likely more contagious than BA.1.\n\nQuestion\n\nCan those infected with the BA.1 get re-infected with BA.2.\n\nFrench Health Minister, Olivier Veran\n\nhttps://www.aljazeera.com/news/2022/1/22/omicron-sub-variant-throws-up-new-virus-questions\n\nWhat we know for now is that BA.2 more or less corresponds to the characteristics that we know of Omicron\n\nRobert Garry, virologist Tulane University School of Medicine\n\nhttps://www.washingtonpost.com/health/2022/01/24/covid-omicron-ba2/\n\nVariants have come, variants have gone\n\nI don\u2019t think there\u2019s any reason to think this one is a whole lot worse than the current version of omicron\n\nJames Musser, Center for Molecular and Translational Human Infectious Diseases Research, Houston Methodist\n\nThe good news is we have only three \n\nWe certainly do not see the 5% and more reported in the U.K\n\nCertainly not the 40% in Denmark\n\nWe know that omicron \u2026 can clearly evade preexisting immunity,\n\nfrom both vaccines and exposure to other variants of the virus,\n\nWhat we don\u2019t know yet is whether son-of-omicron does that better or worse than omicron. \n\nSo that\u2019s an open question.\n\nAnders Fomsgaard, virologist, State Serum Institute Denmark\n\nBA. 2 has become the dominant form of the virus in his nation of nearly 6 million people, \n\nwhere it now accounts for about 65% of new cases \n\nas BA. 1 is on the decline\n\nwe are not so concerned, since we so far do not see major differences in age distribution, vaccination status, breakthrough infections and risk of hospitalization. \n\nAlso, despite the high infection rate of BA. 2, the numbers in ICUs are decreasing\n\n\nFrancois Balloux, professor of computational biology, University College, London\n\nhttps://www.telegraph.co.uk/global-health/science-and-disease/ba2-new-omicron-sub-variant-could-prolong-uk-epidemic-warn-experts/\n\nBA.2 about 20 mutations apart from the original BA.1\n\nthe two omicron sub lineages are sister clades that split from other several months ago, and are not derived from each other\n\nPeople infected with one of the lineages would have \u201crobust immunity\u201d against the other one \n\nAt this stage, BA.1 and BA.2 can be considered as two epidemiologically largely equivalent sub-lineages of omicron", "link": "https://www.youtube.com/watch?v=n09uw2wzF1o", "date_published": "2022-01-26 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Daughter of omicron sound corrected", "description": "Omicron BA.2 Variant, is this going to be another wave?\n\nIf you would like John\u2019s text books, (it is free to download the PDFs)\n\nLink to free download of my 2 textbooks\n\nhttp://159.69.48.3/\n\nPhysiology book in hard copy\nhttps://www.ebay.co.uk/itm/154770452796?mkevt=1&mkcid=16&mkrid=710-127635-2958-0\n\nPathophysiology book in hard copy\nhttps://www.ebay.co.uk/itm/154770451780?mkevt=1&mkcid=16&mkrid=710-127635-2958-0\n\n\nOriginal omicron, B.1.1.529\n\nhttps://www.who.int/en/activities/tracking-SARS-CoV-2-variants/\n\nPANGO Lineage is described as a cluster of sequences that are associated with an epidemiological event,\n\nPhylogenetic Assignment of Named Global Outbreak Lineages (PANGOLIN) \n\nOmicron includes Pango lineage B.1.1.529 and descendent Pango lineages BA.1, BA.1.1, BA.2 and BA.3. \n\nBA.2 is a descendent lineage\n\n\u2018Omicron plus\u2019\n\nIdentified, Philippines, then to India\n\nhttps://www.medpagetoday.com/special-reports/exclusives/96833\n\nhttps://www.independent.co.uk/news/science/covid-omicron-variant-ba2-latest-b2000044.html\n\nOmicron sublineage BA.2\n\n10,000 cases of BA.2, 40 countries\n\nPotentially increased transmissibility over omicron clade BA.1\n\nU.K. Health Security Agency, VUI\n\nCases doubling every 4 days\n\n120% growth advantage over original Omicron clade\n\n(Delta to Omicron, 500% growth advantage)\n\nSimilar growth, Denmark, Norway, Sweden, India\n\nDoes not have the same s-gene target failure on PCR as omicron BA.1\n\nBA.2 is S gene positive\n\nBA.1, 60 mutations\n\nBA.2, 80 mutations\nhttps://www.telegraph.co.uk/global-health/science-and-disease/ba2-new-omicron-sub-variant-could-prolong-uk-epidemic-warn-experts/\n\nMeaghan Kall, UKHSA\n\nhttps://twitter.com/kallmemeg/status/1485198018953555969\n\nno evidence at all yet that it can evade Omicron (BA.1) immunity or be different to Omicron in any meaningful way\n\nVariants will continue to emerge, but not all variants will be a problem\n\nOnly having a transmissibility advantage at this stage of the game (with population immunity so high) isn't a total showstopper\n\nLittle difference in vaccine effectiveness between BA.1 and BA.2\n\nDisease severity, comparable to BA.1\n\nUnlikely to be another BA.2 omicron wave\n\nDenmark\n\nBA.2 now accounts for 65% of new cases\n\nEarly data, not been associated with an increase in hospitalisations\n\nNorway\n\nIncrease in BA.2 in Oslo\nConcurred that BA.2 is likely more contagious than BA.1.\n\nQuestion\n\nCan those infected with the BA.1 get re-infected with BA.2.\n\nFrench Health Minister, Olivier Veran\n\nhttps://www.aljazeera.com/news/2022/1/22/omicron-sub-variant-throws-up-new-virus-questions\n\nWhat we know for now is that BA.2 more or less corresponds to the characteristics that we know of Omicron\n\nRobert Garry, virologist Tulane University School of Medicine\n\nhttps://www.washingtonpost.com/health/2022/01/24/covid-omicron-ba2/\n\nVariants have come, variants have gone\n\nI don\u2019t think there\u2019s any reason to think this one is a whole lot worse than the current version of omicron\n\nJames Musser, Center for Molecular and Translational Human Infectious Diseases Research, Houston Methodist\n\nThe good news is we have only three \n\nWe certainly do not see the 5% and more reported in the U.K\n\nCertainly not the 40% in Denmark\n\nWe know that omicron \u2026 can clearly evade preexisting immunity,\n\nfrom both vaccines and exposure to other variants of the virus,\n\nWhat we don\u2019t know yet is whether son-of-omicron does that better or worse than omicron. \n\nSo that\u2019s an open question.\n\nAnders Fomsgaard, virologist, State Serum Institute Denmark\n\nBA. 2 has become the dominant form of the virus in his nation of nearly 6 million people, \n\nwhere it now accounts for about 65% of new cases \n\nas BA. 1 is on the decline\n\nwe are not so concerned, since we so far do not see major differences in age distribution, vaccination status, breakthrough infections and risk of hospitalization. \n\nAlso, despite the high infection rate of BA. 2, the numbers in ICUs are decreasing\n\n\nFrancois Balloux, professor of computational biology, University College, London\n\nhttps://www.telegraph.co.uk/global-health/science-and-disease/ba2-new-omicron-sub-variant-could-prolong-uk-epidemic-warn-experts/\n\nBA.2 about 20 mutations apart from the original BA.1\n\nthe two omicron sub lineages are sister clades that split from other several months ago, and are not derived from each other\n\nPeople infected with one of the lineages would have \u201crobust immunity\u201d against the other one \n\nAt this stage, BA.1 and BA.2 can be considered as two epidemiologically largely equivalent sub-lineages of omicron", "link": "https://www.youtube.com/watch?v=empdad1VBiQ", "date_published": "2022-01-26 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Study confirms omicron reinfections", "description": "If you would like John\u2019s text books, (it is free to download the PDFs)\n\nLink to free download of my 2 textbooks\n\nhttp://159.69.48.3/\n\nReal-time Assessment of Community Transmission findings, Round 17\n\nREACT-1 study \n\nFunded by the Department of Health and Social Care in England\n\n65% of the infected said they had already previously tested positive for Covid\n\nhttps://www.imperial.ac.uk/medicine/research-and-impact/groups/react-study/real-time-assessment-of-community-transmission-findings/\n\nhttps://www.imperial.ac.uk/media/imperial-college/institute-of-global-health-innovation/R17_final.pdf\n\nhttps://www.imperial.ac.uk/news/233381/fall-coronavirus-infections-england-have-stalled/\n\nRapid transmission of the SARS-CoV-2 Omicron variant has led to the highest ever recorded case incidence levels in many countries around the world. \n\nRT-PCR test results, self-administered throat and nose swabs\n\nRandomly-selected participants in England, n = 100,607\n\nAges 5 years and over\n\nData were collected between 5 and 20 January 2022\n\nTemporal, socio-demographic and geographical spread of the virus\n\nViral loads and viral genome sequence data for positive swabs. \n\nResults\n\nSwab positivity was 4.41%\n\nThree-fold higher than in December 2021 in England\n\n1,406 sequenced positive swabs to 16 January 2022\n\n1392 (99.0%) were Omicron\n\nIncluding 6 (0.43%) cases of BA.2 sub-lineage\n\n14 (1.0%) were Delta\n\nWithin round 17\n\nPrevalence was decreasing overall,\n\nbut increasing in children aged 5 to 17 years\n\nSwab-positivity prevalence\n\n75 years and older, 2.43%\n\n6+ household, OR 1.66\n\nUrban vs rural areas OR 1.24\n\nMost vs least deprived areas OR 1.33\n\nIn adults who received three vs two vaccine doses\n\nHigher Ct values (lower viral load) in rounds 15 and 16\nbut not in round 17\n\nThe distributions of Ct values were similar in unvaccinated and vaccinated children aged 17 years and below in round 15, round 16 and round 17.\n\nPrevalence in those shielding\n\n3.43%\n\nIn those not shielding to 4.61%\n\nConclusions\n\nUnprecedented levels of infection with SARS-CoV-2 in England in January 2022\n\nAlmost complete replacement of Delta by Omicron\n\nVaccination (including the booster campaign) remains the mainstay of the defence\n\ngiven the high levels of protection against hospitalisations. \n\nHowever, further measures beyond vaccination may be required if the very high rates of Omicron infection persist,\n\nDr. Hans Kluge, WHO, Europe\n\nhttps://www.nytimes.com/live/2022/01/24/world/omicron-covid-vaccine-tests\n\nBetween vaccination and natural immunity through infection, \n\nOmicron offers plausible hope for stabilization and normalization\n\nDr. Tedros\n\nBut it\u2019s dangerous to assume that Omicron will be the last variant or that we are in the endgame. \n\nOn the contrary, globally, the conditions are ideal for more variants to emerge. \n\nIt\u2019s true that we will be living with Covid for the foreseeable future\n\na preventable and treatable disease", "link": "https://www.youtube.com/watch?v=c32vDjyNE-M", "date_published": "2022-01-26 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]